Harvard Psychopharmacology: A Master Class 2026

Advanced Psychiatry, Psychopharmacology & Mental Health Treatment

Stay at the forefront of modern psychiatric care with Harvard Psychopharmacology: A Master Class 2026, an advanced educational program designed for clinicians seeking a deeper understanding of contemporary psychopharmacology, clinical neurobiology, complex psychiatric disorders, and emerging treatment strategies.

This comprehensive 2026 update brings together clinically relevant developments across depression, bipolar disorder, schizophrenia, anxiety, sleep medicine, substance use disorders, perinatal psychiatry, child and adolescent psychiatry, and geriatric mental health.

The program also explores rapidly evolving areas including neuromodulation, psychedelic-assisted treatment, artificial intelligence, digital therapeutics, and predictive testing.

Course Information

Course: Harvard Psychopharmacology: A Master Class 2026
Course Dates: March 20–21, 2026
Format: Digital Video Lectures + PDF Materials + English Subtitles
Video Lectures: 19 Videos
Subtitles: 19 VTT Files
PDF Materials: 17 PDFs
Total Size: 6.76 GB
Specialty: Psychiatry • Psychopharmacology • Mental Health • Clinical Neuroscience

What You’ll Learn

This advanced program is structured to help clinicians connect the latest developments in neuroscience and pharmacology with practical psychiatric decision-making.

After reviewing the course material, learners can strengthen their understanding of how to:

• Apply contemporary clinical neurobiology to psychiatric treatment decisions.
• Develop advanced strategies for treatment-resistant depression.
• Approach complicated bipolar disorder and polypharmacy cases.
• Evaluate emerging treatments including neuromodulation and psychedelic-based approaches.
• Understand the evolving role of AI and digital therapeutics in psychiatry.
• Individualize treatment across pediatric, perinatal, adult, and geriatric populations.
• Review modern approaches to schizophrenia and psychotic disorders.
• Improve management strategies for anxiety and sleep disorders.
• Address psychiatric aspects of substance use disorders.
• Evaluate the potential role and limitations of predictive laboratory testing in psychiatric practice.

Major Clinical Areas Covered

Depression & Treatment Resistance

Explore advanced approaches to:

• Major depressive disorder
• Treatment-resistant depression
• Antidepressant selection
• Medication optimization
• Combination and augmentation strategies
• Complex clinical decision-making
• Emerging therapeutic approaches

Bipolar Disorder

Review important considerations involving:

• Bipolar depression
• Mood stabilization
• Complex pharmacotherapy
• Polypharmacy
• Treatment selection
• Difficult-to-manage presentations

Schizophrenia & Psychotic Disorders

Update your understanding of:

• Contemporary antipsychotic treatment
• Medication selection
• Treatment-resistant illness
• Long-term management
• Emerging pharmacologic strategies

Anxiety Disorders

Examine practical approaches to:

• Anxiety disorder pharmacotherapy
• Benzodiazepine use
• Risk-benefit considerations
• Long-term medication strategies
• Treatment of challenging anxiety presentations

Sleep & Psychiatry

Explore the relationship between sleep disorders and psychiatric illness, including how sleep disturbances can affect diagnosis, treatment response, and overall mental health.

Child & Adolescent Psychopharmacology

Review treatment considerations specific to younger patients, including:

• Medication selection
• Developmental considerations
• Safety and tolerability
• Clinical decision-making in pediatric psychiatry

Perinatal Psychiatry

Develop a stronger understanding of psychiatric treatment during:

• Pregnancy
• Postpartum periods
• Reproductive transitions

The course examines the complex balance between maternal mental health, medication considerations, and individualized treatment planning.

Geriatric Psychiatry

Review psychopharmacologic considerations in older adults, including:

• Age-related pharmacologic changes
• Polypharmacy
• Adverse-effect considerations
• Cognitive and psychiatric comorbidities
• Individualized treatment strategies

Emerging Treatments & Future Directions

One of the major strengths of the 2026 program is its attention to rapidly evolving areas of psychiatric care.

Neuromodulation

Review contemporary neuromodulation approaches and their potential role in patients with difficult-to-treat psychiatric illness.

Psychedelic-Based Treatments

Explore emerging evidence and clinical considerations surrounding psychedelic-assisted approaches, including their investigation in PTSD and other psychiatric conditions.

Artificial Intelligence in Mental Health

Understand how AI and digital technologies may influence:

• Clinical assessment
• Treatment selection
• Patient monitoring
• Digital therapeutics
• Psychiatric research
• Future mental healthcare delivery

Predictive Testing

Examine the evolving evidence surrounding laboratory and predictive testing and its potential utility in psychiatric treatment selection.

Course Topics

The program provides focused education across:

Clinical Neurobiology Updates • Advanced Antidepressant Strategies • Treatment-Resistant Depression • Bipolar Disorder • Psychiatric Polypharmacy • Perinatal Psychiatry • Child & Adolescent Psychiatry • Neuromodulation • Geriatric Psychiatry • Schizophrenia • Sleep Medicine • AI in Mental Health • Digital Therapeutics • Psychedelic Therapies • PTSD • Substance Use Disorders • Anxiety Disorders • Benzodiazepines • Predictive Laboratory Testing

Who Should Study This Course?

The program is particularly relevant for:

Psychiatrists • Psychiatric Nurse Practitioners • Primary Care Physicians • Mental Health Clinicians • Residents • Fellows • Prescribing Healthcare Professionals

It may be especially valuable for clinicians who regularly encounter patients with complex, treatment-resistant, or comorbid psychiatric conditions.

Why This 2026 Update Is Important

Psychiatric treatment is changing rapidly.

Clinicians must increasingly navigate not only traditional psychopharmacology, but also advances in neuroscience, precision medicine, neuromodulation, digital mental health, AI, and emerging therapeutic modalities.

At the same time, effective clinical practice requires careful consideration of individual factors such as age, pregnancy, comorbidities, previous treatment response, polypharmacy, adverse effects, and treatment resistance.

Harvard Psychopharmacology: A Master Class 2026 brings these areas together in a focused educational program designed to connect new scientific developments with practical psychiatric care.

Key Benefits

✓ Advanced Psychopharmacology Update — Review important 2026 developments in psychiatric medication management.

✓ 19 Expert Video Lectures — Structured video education covering major areas of contemporary psychiatry.

✓ 17 PDF Resources — Accompany the lectures with additional educational materials.

✓ 19 English Subtitle Files — Follow presentations more conveniently and review complex concepts.

✓ Complex Clinical Cases — Strengthen decision-making for difficult and treatment-resistant presentations.

✓ Across-the-Lifespan Coverage — Pediatric, perinatal, adult, and geriatric psychiatry.

✓ Emerging Therapies — Explore neuromodulation, psychedelic approaches, AI, and digital therapeutics.

✓ Broad Psychiatric Coverage — Depression, bipolar disorder, schizophrenia, anxiety, sleep, substance use, and more.

Complete Digital Course Bundle

19 Videos + 17 PDFs + 19 English Subtitles

6.76 GB of Educational Content

March 20–21, 2026

Harvard Psychopharmacology: A Master Class 2026

A comprehensive educational resource for clinicians seeking an advanced review of psychopharmacology, psychiatric treatment, clinical neuroscience, treatment-resistant disorders, and emerging mental health therapies